State Street Corp Biomarin Pharmaceutical Inc Transaction History
State Street Corp
- $2.21 Trillion
- Q1 2024
A detailed history of State Street Corp transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, State Street Corp holds 6,895,215 shares of BMRN stock, worth $568 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
6,895,215
Previous 6,730,515
2.45%
Holding current value
$568 Million
Previous $649 Million
7.2%
% of portfolio
0.03%
Previous 0.03%
Shares
17 transactions
Others Institutions Holding BMRN
# of Institutions
623Shares Held
181MCall Options Held
1.73MPut Options Held
1.73M-
Primecap Management CO Pasadena, CA18.7MShares$1.54 Billion1.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.1MShares$1.49 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$1.19 Billion0.03% of portfolio
-
Dodge & Cox San Francisco, CA14MShares$1.15 Billion0.75% of portfolio
-
Capital Research Global Investors Los Angeles, CA6.52MShares$537 Million0.13% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $15.3B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...